Application note: Direct PCR from blood using Platinum SuperFi DNA Polymerase
Posted: 14 December 2016 | Thermo Fisher Scientific | 2 comments
This application note describes how researchers can successfully perform PCR from blood samples without DNA purification using Platinum SuperFi DNA Polymerase…
Invitrogen™ Platinum™ SuperFi™ DNA Polymerase is engineered with a DNA-binding domain resulting in high processivity and increased resistance to PCR inhibitors present in blood, as well as to most widely used blood preservatives (e.g., heparin, EDTA, citrate).
This application note describes how researchers can successfully perform PCR from blood samples without DNA purification using Platinum SuperFi DNA Polymerase. Multiplex PCR can also be used to amplify more than one target sequence directly from blood. This protocol minimizes sample loss and helps significantly reduce protocol time with no DNA purification or isolation steps.
Materials and methods
- Whole blood
- Invitrogen™ Platinum™ SuperFi™ PCR Master Mix (Cat. No. 12358010) or Platinum SuperFi DNA Polymerase (Cat. No. 12351010)
- Invitrogen™ dNTP Mix (10 mM each, Cat. No. 18427013; only required for stand-alone enzyme)
- Forward and reverse primers
- 50 mM MgCl2
- Invitrogen™ E-Gel™ General Purpose Agarose Gels or equivalent
This application note is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- ebook: Twin-screw extrusion for pharmaceutical applications
- Biopharmaceuticals contributing to manufacturing outsourcing trend
- Biologics driving continuous bioprocessing market expansion
- Mycoplasma testing market expected to value nearly $2 million by 2031
- Drug development trends: insight from Thermo Fisher’s Anil Kane
Request for the detailed about application note Direct PCR from blood using Platinum SuperFi DNA Polymerase”
interested in your platinum solutions